Vault-13

Knoll Capital Management, LLC

MIAMI, FL · CIK 1325083 · 13F filing filed 2024-02-14

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$120.8m reported value +25.4% vs Q3 2023
32positions
74.2%in top 10
4 new 9 added 1 reduced 9 sold out vs Q3 2023

Holdings, Q4 2023

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 BIOHAVEN PHARMACTL HLDG CO L COM BHVN BHVN 490,422 $21.0m17.38% 17.38% UnchangedShares held: Q1 2023 450.4k, Q2 2023 450.4k, Q3 2023 490.4k, Q4 2023 490.4k
2 ALDEYRA THERAPEUTICS INC COM ALDX ALDX 5,475,516 $19.2m15.92% 15.92% AddedShares held: Q1 2023 2.1m, Q2 2023 3.0m, Q3 2023 3.0m, Q4 2023 5.5m +2.4m +2,443,601 80.6%
3 APPLIED THERAPEUTICS INC COM APLT APLT 5,474,687 $18.3m15.19% 15.19% AddedShares held: Q1 2023 3.5m, Q2 2023 3.5m, Q3 2023 5.2m, Q4 2023 5.5m +312.6k +312,599 6.1%
4 AVADEL PHARMACEUTICALS PLC SPONSORED ADR SPONSORED ADR 600,000 $8.5m7.02% 7.02% UnchangedShares held: Q1 2023 0, Q2 2023 500.0k, Q3 2023 600.0k, Q4 2023 600.0k
5 GLOBAL X FDS GLOBAL X SILVER SIL SIL 176,000 $5.0m4.13% 4.13% AddedShares held: Q1 2023 89.7k, Q2 2023 89.7k, Q3 2023 89.7k, Q4 2023 176.0k +86.3k +86,300 96.2%
6 HOOKIPA PHARMA INC COM COM 5,517,385 $4.5m3.70% 3.70% UnchangedShares held: Q1 2023 300.0k, Q2 2023 5.5m, Q3 2023 5.5m, Q4 2023 5.5m
7 VERONA PHARMA PLC SPONSORED ADS VRNA VRNA 200,000 $4.0m3.29% 3.29% UnchangedShares held: Q1 2023 200.0k, Q2 2023 200.0k, Q3 2023 200.0k, Q4 2023 200.0k
8 SILVERCREST METALS INC COM SIL SIL 470,000 $3.1m2.55% 2.55% AddedShares held: Q1 2023 170.0k, Q2 2023 170.0k, Q3 2023 410.0k, Q4 2023 470.0k +60.0k +60,000 14.6%
9 AGNICO EAGLE MINES LTD COM AEM AEM 55,500 $3.0m2.52% 2.52% AddedShares held: Q1 2023 0, Q2 2023 0, Q3 2023 40.0k, Q4 2023 55.5k +15.5k +15,500 38.8%
10 SEABRIDGE GOLD INC COM COM 246,597 $3.0m2.48% 2.48% UnchangedShares held: Q1 2023 80.0k, Q2 2023 80.0k, Q3 2023 246.6k, Q4 2023 246.6k
11 WHEATON PRECIOUS METALS CORP COM WPM WPM 60,000 $3.0m2.45% 2.45% AddedShares held: Q1 2023 0, Q2 2023 0, Q3 2023 47.5k, Q4 2023 60.0k +12.5k +12,500 26.3%
12 VANECK ETF TRUST GOLD MINERS ETF GDX GDX 91,850 $2.8m2.36% 2.36% UnchangedShares held: Q1 2023 91.8k, Q2 2023 91.8k, Q3 2023 91.8k, Q4 2023 91.8k
13 KINROSS GOLD CORP COM KGC KGC 440,000 $2.7m2.20% 2.20% UnchangedShares held: Q1 2023 0, Q2 2023 0, Q3 2023 440.0k, Q4 2023 440.0k
14 ENTERA BIO LTD SHS ENTX ENTX 3,881,879 $2.3m1.93% 1.93% AddedShares held: Q1 2023 2.5m, Q2 2023 2.5m, Q3 2023 2.5m, Q4 2023 3.9m +1.4m +1,397,604 56.3%
15 ALTIMMUNE INC COM NEW ALT ALT 200,000 $2.2m1.86% 1.86% NewShares held: Q1 2023 173.9k, Q2 2023 173.9k, Q3 2023 0, Q4 2023 200.0k
16 EQUINOX GOLD CORP COM EQX EQX 420,929 $2.1m1.70% 1.70% UnchangedShares held: Q1 2023 0, Q2 2023 0, Q3 2023 420.9k, Q4 2023 420.9k
17 VANECK ETF TRUST JUNIOR GOLD MINE GDXJ GDXJ 53,150 $2.0m1.67% 1.67% UnchangedShares held: Q1 2023 53.1k, Q2 2023 53.1k, Q3 2023 53.1k, Q4 2023 53.1k
18 BOOZ ALLEN HAMILTON HLDG COR CL A BAH BAH 13,000 $1.7m1.38% 1.38% UnchangedShares held: Q1 2023 13.0k, Q2 2023 13.0k, Q3 2023 13.0k, Q4 2023 13.0k
19 VISA INC COM CL A V V 4,850 $1.3m1.04% 1.04% UnchangedShares held: Q1 2023 4.8k, Q2 2023 4.8k, Q3 2023 4.8k, Q4 2023 4.8k
20 CVS HEALTH CORP COM CVS CVS 14,500 $1.1m0.95% 0.95% UnchangedShares held: Q1 2023 14.5k, Q2 2023 14.5k, Q3 2023 14.5k, Q4 2023 14.5k
21 THERMO FISHER SCIENTIFIC INC COM TMO TMO 2,100 $1.1m0.92% 0.92% UnchangedShares held: Q1 2023 2.1k, Q2 2023 2.1k, Q3 2023 2.1k, Q4 2023 2.1k
22 MAG SILVER CORP COM MAG MAG 105,000 $1.1m0.91% 0.91% ReducedShares held: Q1 2023 0, Q2 2023 0, Q3 2023 160.0k, Q4 2023 105.0k -55.0k -55,000 -34.4%
23 ALAMOS GOLD INC NEW COM CL A AGI AGI 80,000 $1.1m0.89% 0.89% UnchangedShares held: Q1 2023 0, Q2 2023 0, Q3 2023 80.0k, Q4 2023 80.0k
24 NORTHROP GRUMMAN CORP COM NOC NOC 2,165 $1.0m0.84% 0.84% UnchangedShares held: Q1 2023 2.2k, Q2 2023 2.2k, Q3 2023 2.2k, Q4 2023 2.2k
25 PHILIP MORRIS INTL INC COM PM PM 10,000 $1.0m0.84% 0.84% NewShares held: Q1 2023 0, Q2 2023 0, Q3 2023 0, Q4 2023 10.0k
26 ISHARES TR US AER DEF ETF ITA ITA 7,650 $968.5k0.80% 0.80% NewShares held: Q1 2023 0, Q2 2023 0, Q3 2023 0, Q4 2023 7.7k
27 NEW PAC METALS CORP COM NEWP NEWP 485,000 $926.4k0.77% 0.77% AddedShares held: Q1 2023 0, Q2 2023 0, Q3 2023 131.7k, Q4 2023 485.0k +353.3k +353,346 268.4%
28 ROYAL GOLD INC COM RGLD RGLD 7,550 $913.2k0.76% 0.76% UnchangedShares held: Q1 2023 0, Q2 2023 0, Q3 2023 7.5k, Q4 2023 7.5k
29 OCULAR THERAPEUTIX INC COM OCUL OCUL 200,400 $893.8k0.74% 0.74% AddedShares held: Q1 2023 200.0k, Q2 2023 200.0k, Q3 2023 400, Q4 2023 200.4k +200.0k +200,000 50000.0%
30 MEREO BIOPHARMA GROUP PLC SPON ADS MREO MREO 160,470 $370.1k0.31% 0.31% NewShares held: Q1 2023 0, Q2 2023 0, Q3 2023 0, Q4 2023 160.5k
31 Orgenesis, Inc. COM COM 634,738 $317.4k0.26% 0.26% UnchangedShares held: Q1 2023 634.7k, Q2 2023 634.7k, Q3 2023 634.7k, Q4 2023 634.7k
32 OPUS GENETICS INC COM IRD IRD 100,000 $301.0k0.25% 0.25% UnchangedShares held: Q1 2023 100.0k, Q2 2023 100.0k, Q3 2023 100.0k, Q4 2023 100.0k

Sold out since Q3 2023

SecurityTickerShares held beforeValue then
FRANCO NEV CORP FNV FNV 14,500 $1.9m14.5k shares
FIRST MAJESTIC SILVER CORP AG AG 275,000 $1.4m275.0k shares
ALTRIA GROUP INC MO MO 22,700 $954.5k22.7k shares
LOCKHEED MARTIN CORP LMT LMT 2,150 $879.3k2.1k shares
PAN AMERN SILVER CORP PAAS PAAS 54,085 $783.1k54.1k shares
OSISKO GOLD ROYALTIES LTD 400,000 $732.0k400.0k shares
AMYLYX PHARMACEUTICALS INC AMLX AMLX 24,772 $453.6k24.8k shares
OMEGA THERAPEUTICS INC 173,010 $372.0k173.0k shares
BIOXCEL THERAPEUTICS INC 60,000 $151.8k60.0k shares

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
ELICIO THERAPEUTICS INC ELTX · 13G · filed 2026-07-08 ELTX 5.3%≈ $4.7m +0.1 pts 13G 2026-07-08